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In the biosynthesis of complex polyketides, acyl-
transferase domains (ATs) are key determinants of
structural diversity. Their specificity and position in
polyketide synthases (PKSs) usually controls the
location and structure of building blocks in polyketi-
des. Many bioactive polyketides, however, are
generated by trans-AT PKSs lacking internal AT
domains. They were previously believed to use
mainly malonyl-specific free-standing ATs. Here,
we report a mechanism of structural diversification,
in which the trans-AT KirCII regiospecifically incor-
porates the unusual extender unit ethylmalonyl-CoA
in kirromycin polyketide biosynthesis.
INTRODUCTION
Many important bacterial drugs are synthesized by polyketide
synthases (PKS), which work as assembly lines (Hertweck,
2009). Type I PKSs are large multifunctional enzymes, which
have a complex, modular organization. Each PKS module
contains a set of catalytic domains that perform one elongation
step of the polyketide chain. A classical type I PKS module
includes three essential domains—an acyltransferase (AT), a ke-
tosynthase (KS), and an acyl carrier protein (ACP). The enzymatic
role of ATs is the selection and loading of extender units, usually
coenzyme A–activated carboxylic acids, onto holo-ACPs. The
KS domain is responsible for the condensation of these building
blocks in polyketide assembly. Further modifications during the
chain elongation process are performed by optional domains,
which are often present in such multifunctional enzymes and
contribute to the high structural variability of their products.
This variability is further increased by the ability to incorporate
various extender units at the different modules. The extender
unit specificity is conferred by the internal AT domains.
During the last decade, variants in the PKS architecture have
been described, in which AT domains are not present in the
megaenzyme but instead act as discrete enzymes (trans-AT438 Chemistry & Biology 18, 438–444, April 22, 2011 ª2011 ElsevierPKS type) (Staunton and Weissman, 2001; Piel, 2010). In most
of such assembly lines, malonyl-CoA is used as extender unit,
although the transfer of malonyl-CoA to ACPs by trans-acting
ATs was biochemically confirmed only for leinamycin (Cheng
et al., 2003), bacillaene (Calderone et al., 2006), and bryostatin
(Lopanik et al., 2008). Whereas in cis-AT PKS different extender
units are commonly incorporated, in trans-AT PKSs structural
variability is enhanced by the frequent inclusion of additional
modifying domains (e.g., methyltransferases into the PKS
modules). Currently, there are only few reports of extender units
different from malonyl-CoA in trans-AT pathways. For example,
in oxazolomycin biosynthesis, the transfer of methoxymalonyl-
CoA by OzmC was postulated on the basis of mutational anal-
yses (Zhao et al., 2010). In the sorangicin biosynthetic pathway,
the involvement of a discrete AT in loading hydroxymalonyl-CoA
was proposed (Irschik et al., 2010).
Recently, the transfer of a (2S)-aminomalonyl extender unit to
ACP1 of the PKS ZmaA has been described for zwittermicin
biosynthesis (Chan and Thomas, 2010). In this case, the
substrate for the AT ZmaA is already attached to the type II
ACPZmaH. Toour knowledge, the direct loading of free, nonmal-
onate precursors by trans-ATs has not yet been biochemically
confirmed.
In kirromycin biosynthesis, the incorporation of ethylmalonyl-
CoA was suggested (Weber et al., 2008). This compound
(Wolf et al., 1974) is the prototypemember of the elfamycin family
of antibiotics, which inhibit protein biosynthesis by interfering
with the bacterial elongation factor EF-Tu. Interestingly, the
producer strain Streptomyces collinus Tu¨ 365 has a kirromycin
sensitive EF-Tu (Olsthoorn-Tieleman et al., 2007). Nevertheless
S. collinus is able to survive when the antibiotic is produced.
Thus, there has to be a specific resistance mechanism that was
not identified yet. Kirromycin is a narrow-spectrum antibiotic; it
exhibits activity against, for example, streptococci, some entero-
cocci, Neisseria gonorrhoeae, Haemophilus influenza, and the
malaria parasite Plasmodium falciparum.
The antibiotic is synthesized by a complex of type I PKS and
nonribosomal peptide synthetases (Weber et al., 2008; Laiple
et al., 2009). This assembly line is encoded by the genes kirAI-
kirAVI and kirB. KirAI-AV are multifunctional enzymes of the
trans-AT PKS type, whereas KirAVI belongs to the canonicalLtd All rights reserved
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Figure 1. Kirromycin Production Assay
(A) HPLC/ESI-MS analysis of extracts of the wild-type S. collinus Tu¨ 365. Left: HPLC UV/Vis trace. Right: mass spectrum of kirromycin (negative mode).
(B) HPLC/ESI-MS analysis of extracts of the mutant DkirCII carrying the vector pRM4.
(C) HPLC/ESI-MS analysis of extracts of the complemented mutant DkirCII pEM11CII. Left: HPLC UV/Vis trace. Right: mass spectrum of kirromycin (negative
mode).
See also Figures S1 and S2.
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Supramolecular Templating in Kirromycin Biosynthesiscis-AT PKS type and contains internal AT domains (see Figure S1
available online). Such cis and trans AT-PKS mixtures are found
very rarely (e.g., in the biosynthetic pathway of psymberin) (Fisch
et al., 2009).
Although most condensation steps during the biosynthesis of
the kirromycin carbon skeleton are performedwithmalonyl-CoA,
at module 5 of KirAII, an ethylmalonyl-CoA unit is integrated.
Thus, the question arises how the loading specificity of different
extender units to the PKS is accomplished in kirromycin
biosynthesis.
In the kirromycin gene cluster, two genes, kirCI and kirCII,
encode putative ATs (Figure S1) (Weber et al., 2008). The
trans-AT KirCI is similar to MmpC from Pseudomonas
fluorescens, which seems to be the malonyl-CoA–specific AT
in mupirocin biosynthesis (El Sayed et al., 2003; Thomas et al.,
2010). KirCII is related to an AT domain in the stigmatellin cis-AT
type PKS StiA (Gaitatzis et al., 2002) from Stigmatella aurantiaca
(47% identity, 60%similarity, UniProt-Acc: Q8RJY6). In phyloge-
netic analyses, StiA is a member of a clade of mostly methylma-
lonyl-CoA–specific ATs that also contains cis-AT domains with
other extender unit specificities. Because of this similarity, weChemistry & Biology 18,hypothesized that KirCII could have the required ethylmalonyl-
CoA specificity.
RESULTS AND DISCUSSION
To confirm the involvement of KirCII in the biosynthesis of
kirromycin, a gene inactivation mutant was generated, in which
the putative AT gene, kirCII, was replaced by a thiostrepton
resistance cassette (see Supplemental Experimental Proce-
dures). The genotype of the resultant mutant, DkirCII, was
confirmed by Southern hybridization and PCR (Figure S2).
HPLC-MS analyses of culture extracts showed that this mutant
lost its ability to produce kirromycin (Figures 1A and 1B). These
results confirm that KirCII is essential for kirromycin biosyn-
thesis. The complementation of the kirCII gene replacement
mutant restored kirromycin production to the wild-type level
(Figure 1C), showing that the lack of antibiotic production in
the mutant was caused by the deletion of the kirCII gene and
not by polar effects due to the incorporation of the resistance
cassette. In contrast to leinamycin (Cheng et al., 2003) and
virginiamycin (Pulsawat et al., 2007), where an overproduction438–444, April 22, 2011 ª2011 Elsevier Ltd All rights reserved 439
Table 1. Effects of Overexpression of kirCII in the Wild-Type
Kirromycin Producer Strain Streptomyces collinus Tu¨ 365
Strain
Kirromycin Concentration (mg/l),
Mean ± SD
Wild-type
S. collinus Tu¨ 365
9.0 ± 1.0
S. collinus pRM4 14.0 ± 5.6
S. collinus pEM11CII 16.6 ± 9.4
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expression of kirCII in the wild-type S. collinus did not result in
a significantly higher kirromycin production (Table 1). However,
the high fluctuation of kirromycin yield in the kirCII overproduc-
tion strain might indicate detrimental effects of the overexpres-
sion on cell growth and thus may influence our observations.
For biochemical characterization of the substrate specificity of
KirCII and its ability to transfer acyl-CoAs to selected ACPs, an
in vitro ACP-loading assay was performed. This assay consists
of two steps: first, apo-ACP to holo-ACP activation, and then,
the loading of holo-ACPs by the trans AT KirCII. We selected
ACP4 of module 4, which according to the structure of kirromy-
cin should be a malonyl carrier, and ACP5 of module 5, for which
ethylmalonyl incorporation was predicted (Weber et al., 2008).
The apo-ACPs and the putative AT KirCII were expressed as
His6-tagged fusion proteins and purified from Escherichia coli
(Figure S3). The inactive apo-ACP4 and apo-ACP5 were
converted to their functional holo forms by the phosphopante-
theinyl transferase Sfp from Bacillus subtilis (Quadri et al.,
1998) in the presence of CoA. Phosphopantetheinylation was
monitored by HPLC and ESI-MS analysis until the apo-ACPs
were fully activated. The resultant holo-ACPs were then used
to determine the ACP-loading ability of KirCII for different CoA
substrates malonyl-CoA, methylmalonyl-CoA, and ethylma-
lonyl-CoA. Because ethylmalonyl-CoA was not commercially
available, unlabeled ethylmalonyl-CoA was synthesized accord-
ing to Taoka et al. (1994).
Each holo-ACP and KirCII was incubated in the presence of
the acyl-CoAs. The reactions were quenched by quick-freezing
and were analyzed by HPLC/ESI-MS.
The loading assay of holo-ACP5 using KirCII and ethylmalonyl-
CoA as substrate resulted in an additional UV peak in the
HPLC-chromatogram (Figure 2B and Table 2). The mass of the
new ACP species corresponded exactly to the calculated
mass of ethylmalonyl-holo-ACP5 (mass for EM-holo-ACP5,
16702.7). This mass was never observed in control reactions
without KirCII. These results confirm that the transfer activity
was performed by the trans-AT KirCII. When using the MagTran
protein deconvolution software (Zhang and Marshall, 1998) on
the mass spectrometry data of the loading assay containing
KirCII, EM-CoA and holo-ACP4, no mass peak of EM-ACP4
could be extrapolated. Only the mass of holo-ACP4 was present
(Figure 2A). On manual inspection of the raw mass spec data,
small peaks corresponding to ethylmalonylylated ACP4 could
be identified indicating a very weak loading also of ACP4 (Fig-
ure S6C; Table 2). These data show that KirCII strongly prefers
holo-ACP5 over holo-ACP4 as the target carrier protein under
the in vitro assay conditions and thus can distinguish between
the ACPs of different PKS modules.440 Chemistry & Biology 18, 438–444, April 22, 2011 ª2011 ElsevierTo confirm the predicted molecular weight of the ACPs and to
ensure that the detected transfer activity in the ACP-loading
assay was performed by KirCII and not by any copurified,
contaminating transferases from E. coli, control reactions were
performed. As a negative control, crude extracts of an E. coli
strain carrying the empty pET expression plasmid were prepared
and purified by the identical protocol as applied for KirCII. The
enriched E. coli proteins, termed ‘‘pET52-proteins,’’ and KirCII,
respectively, were added to the holo-ACPs. In the negative
control, in which the ‘‘pET52-proteins’’ were tested, no transfer
activity was present. As positive control, acyl-phosphopante-
theinyl-groups were directly transferred to apo-ACPs by Sfp,
which has low specificity toward its CoA-substrates (Sunbul
et al., 2009). The products obtained in the positive control
reactions corresponded to the calculated masses of loaded
holo-ACPs and were used as a reference for successful transfer
(Figures S4 and S5; Table 2). Additionally, to exclude self-loading
of holo-ACPs, which was described for type II PKS and the fatty
acid ACPs PfACP and BnACP (Arthur et al., 2006; Misra et al.,
2007), both ACPs, holo-ACP4 and holo-ACP5, without KirCII,
were incubated with the tested substrates. No loading activity
was observed in these samples.
To further narrow down the specificity of KirCII, also the typical
PKS extender units malonyl- and methylmalonyl-CoA were
tested. For both substrates, no transfer activity of KirCII to either
ACP4 and ACP5 was detected by HPLC-MS. Only holo-ACP
masses were found in those reactions (Figures S6A, S6B, and
S7; Table 2).
In addition to the HPLC-MS–based assay, autoradiography
was used as a second, more sensitive detection method. To
perform this assay, the samples including ACPs were incubated
with 14C-labeled malonyl-CoA or methylmalonyl-CoA. The reac-
tions were quenched by addition of cold acetone and subjected
to SDS-PAGE and phosphorimaging (Figure 3). The loading
assay was performed with the same ACPs and control reactions
described above. The autoradiogram displayed clear signals for
the positive controls, showing that Sfp loaded the 14C-substrate
directly onto the apo-ACPs. No loading activity was detected in
the negative controls, where the holo-ACPs were incubated with
‘‘pET52-proteins’’ in the absence of KirCII. Also in the presence
of KirCII, no transfer of [1,3-14C]-malonyl and [1,3-14C]-methyl-
malonyl, respectively, was observed.
SIGNIFICANCE
Our results, confirmed by two different methods, demon-
strate that the trans-AT KirCII is not able to use malonyl-
or methylmalonyl-CoA to load the tested acyl carrier
proteins. Therefore, the ethylmalonyl-loading KirCII repre-
sents the first biochemically characterized discrete AT
with proven specificity and ACP-loading activity for a non-
malonyl unit. Kirromycin is synthesized as a main compo-
nent of Streptomyces collinus Tu¨ 365, and no derivatives
are reported in which ethylmalonyl-CoA is incorporated at
other positions of the molecule backbone. Thus, the recog-
nition mechanism that results in the specific interaction of
the AT KirCII with the ACP of module 5 is at least in part
governed by the ACP. Protein template–directed docking
of free-standing proteins that provide building blocks is anLtd All rights reserved
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Figure 2. HPLC/ESI-MS Analysis of the ACP4/ACP5-Loading Assay with Ethylmalonyl-CoA as Substrate for KirCII
(A) ACP4.
(B) ACP5.
(I) Negative control containing ACP4/ACP5, pET52-proteins, no KirCII. (II) Loading assay containing ACP4/ACP5, ethylmalonyl-CoA, and KirCII. Left: HPLC UV/
Vis trace. Central: mass spectrum. Right: deconvoluted spectrum generated with MagTran 1.03 (Zhang and Marshall, 1998).
See also Figures S3, S6, and S7.
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Table 2. Mass Spectrometric Analysis of In Vitro ACP Loading
Samplea Detected Massb Standard Deviationb Calculated Mass
ACP4
apo-ACP4 17993.7 0.8 17992.1
holo-ACP4 (Sfp loading, pos. control) 18333.9 0.8 18332.5
M-holo-ACP4 (Sfp loading, pos. control) 18420.7 1.8 18418.5
MM-holo-ACP4 (Sfp loading, pos. control) 18434.6 1.6 18432.5
EM-holo-ACP4 (Sfp loading, pos. control) 18449.1 1.9 18446.6
M-holo-ACP4 (KirCII loading) Not detected — 18418.5
MM-holo-ACP4 (KirCII loading) Not detected — 18446.6
EM-holo-ACP4 (KirCII loading) (18446.2)c 8.4 18446.6
ACP5
apo-ACP5 16249.6 0.5 16248.3
holo-ACP5 (Sfp loading, pos. control) 16589.8 1.2 16588.6
M-holo-ACP5 (Sfp loading, pos. control) 16674.6 1.3 16674.6
MM-holo-ACP5 (Sfp loading, pos. control) 16688.3 1.4 16688.7
EM-holo-ACP5 (Sfp loading, pos. control) 16704.7 1.2 16702.7
M-holo-ACP5 (KirCII loading) Not detected — 16674.6
MM-holo-ACP5 (KirCII loading) Not detected — 16688.7
EM-holo-ACP5 (KirCII loading) 16703.9 1.2 16702.7
See also Figures S4 and S5.
aM-holo-ACP: malonyl-holo-ACP, MM-holo-ACP: methylmalonyl-holo-ACP, EM-holo-ACP: ethylmalonyl-holo-ACP.
bCharge deconvolution/mass determination was performed with the ESIprot (Winkler, 2010) software.
c Small peaks of EM-holo-ACP4, which were not present in the control reaction, could only be detected manually in the protein ms data.
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Supramolecular Templating in Kirromycin Biosynthesisalternative mechanism to achieve structural diversity in pol-
yketides. KirCII is a novel example of such supramolecular
templating in antibiotic biosynthesis. This enzyme and its
ethylmalonyl-CoA specificity can now provide conceptually
novel opportunities to genetically engineer the structural
diversity of polyketides.
EXPERIMENTAL PROCEDURES
For general methods, strains, and cultivations see Supplemental Experimental
Procedures.
Generation of the kirCII Gene Inactivation Mutant DkirCII
Flanking regions of kirCII with sizes of 2 kb were amplified using cosmid 1C24
(Weber et al., 2008) as template and the primers lkirCII-5Eco, lkirCII-3Xba,
rkirCII-5Xba, and rkirCII-3Hind (for primer sequences and PCR programs,
see section II.10 of Supplemental Experimental Procedures). A thiostrepton
resistance cassette from plasmid pSLE60 and the promoter region of the
erythromycin resistance gene, PermE from the vector pRM4 (Menges et al.,
2007) were amplified with corresponding primers, thio50XbaI, thio30Bgl2fuse
and fuseBglermE50, ermE30Xba, respectively. To achieve a fusion of the result-
ing products, thioR and PermE, a second PCR using these fragments and the
primers thio50XbaI and ermE30Xba was performed. The fused amplicon
thioRPermE and the PCR products, lkirCII and rkirCII were individually cloned
into pDrive (QIAGEN). lkirCII was excised from pDrive with EcoRI and XbaI
and cloned into the EcoRI/XbaI-digested pA18mob, yielding pA18-lkirCII.
Subsequently, rkirCII was introduced into this plasmid by XbaI/HindIII restric-
tion and ligation, yielding pA18-lrkirCII. To clone the thioRPermE cassette
between the two fragments of pA18-lrkirCII, the thioRPermE was inserted into
the XbaI side of pA18-lrkirCII. The correct orientation of the thioRPermE
cassette was confirmed by control restrictions of the obtained plasmid
pEM10DCII. A double crossover mutant was generated according to methods
described by Weber et al. (2008) and verified by PCR with primers CIIintern1
and CIIintern2 and Southern hybridization.442 Chemistry & Biology 18, 438–444, April 22, 2011 ª2011 ElsevierComplementation of theMutantDkirCII andHomologousExpression
of kirCII in S. collinus Tu¨ 365
The kirCII gene of S. collinus Tu¨ 365 was amplified from cosmid 1C24 using the
primers YTkirCII-NdeStrep-50 and YTkirCII-Hind-30 (for primer sequences, see
section II.10 of Supplemental Experimental Procedures) and was cloned into
the vector pRM4, resulting in the plasmid pEM11CII (for detailed cloning
procedures, see Supplemental Experimental Procedures). Interegeneric
conjugation was used to transfer the plasmids pRM4 (negative control) and
pEM11CII into the gene inactivation mutant DkirCII and the wild-type strain
S. collinus Tu¨ 365.
Protein Expression and Purification
ACP4, ACP5, and kirCII were amplified by PCR (for primers, see section II.10
of Supplemental Experimental Procedures) and were cloned into the vector
pET-52 3C/LIC. The protein expression was performed in the E. coli
strain Rosetta2(DE3)pLysS under different conditions (see section II.11 of
Supplemental Experimental Procedures). The proteins ACP4, ACP5, and
KirCII were purified by Ni-NTA affinity chromatography and ion exchange
chromatography according to section II.6 of Supplemental Experimental
Procedures.
ACP-Loading Assay
To investigate the substrate specificity and ACP-loading ability of KirCII, an
in vitro assay was established. The ACP-loading assay was performed in two
steps, the apo- to holo-ACP phosphopantetheinylation and holo-ACP-loading
by KirCII.
In Vitro Activation of apo-ACP to holo-ACP
ACPs expressed in E. coli were purified as nonphosphopantetheinylated
apo-ACPs. To apply them in the loading assay, a conversion to their active
holo-ACP form is necessary. The apo-ACP activation was performed using
the B. subtilis phosphopantetheinyl transferase Sfp in presence of coenzyme
A. The phosphopantetheinylation reaction contained following components:
100 mM apo-ACP4/5, 10–15 mM Sfp, 0.8–1 mM coenzyme A (Sigma), and
50–60 mM MgCl2 in final volume of 400 ml (reaction buffer: 50 mM Tris-HClLtd All rights reserved
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Figure 3. Autoradiographic Analysis of the ACP4/ACP5-Loading
Assay with [14C]malonyl-/[14C]methylmalonyl-CoA as Substrates
for KirCII
(A) Coomassie Brilliant Blue–stained gels and autoradiograms of the (I) ACP4-
and (II) ACP5-loading assay with [14C]malonyl-CoA. Lane 1: positive
control reaction for ACP4 containing apo-ACP4 and Sfp (detected signal is
[14C]malonyl-holo-ACP4); lane 2: negative control for holo-ACP4 containing
pET52-proteins, no KirCII; lane 3: holo-ACP4 and KirCII; lane 4: holo-ACP5
and KirCII; lane 5: positive control reaction for ACP5 containing apo-ACP5 and
Sfp (detected signal is [14C]malonyl-holo-ACP5); lane 6: negative control for
holo-ACP5 containing pET52-proteins, no KirCII.
(B) Coomassie Brilliant Blue–stained gels and autoradiograms of the (I) ACP4-
and (II) ACP5- loading assay with [14C]methylmalonyl-CoA. Lane 1: holo-ACP4
and KirCII; lane 2: positive control reaction for ACP4 containing apo-ACP4 and
Sfp (detected signal is [14C]methylmalonyl-holo-ACP4); lane 3: negative
control for holo-ACP4 containing pET52-proteins, no KirCII; lane 4: positive
control reaction for ACP5 containing apo-ACP5 and Sfp (detected signal is
[14C]methylmalonyl-holo-ACP5); lane 5: negative control for holo-ACP5
containing pET52-proteins, no KirCII; lane 6: holo-ACP5 and KirCII.
See also Figure S3.
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Supramolecular Templating in Kirromycin Biosynthesis[pH 7.5]). The mixture was incubated first for 1 hr at 37C and then at 4C until
complete conversion to holo-ACPswas achieved. The reaction wasmonitored
by HPLC/ESI-MS.In Vitro ACP-Loading Catalyzed by KirCII
To study the ability of KirCII to acylate various acyl carrier proteins, the
holo-ACPs were incubated with KirCII and acyl-CoA precursors. The reactions
were analyzed by HPLC/ESI-MS or autoradiography analysis.HPLC/ESI-MS Analysis
Malonyl-CoA was obtained from Fluka, and methylmalonyl-CoA was obtained
from Sigma. Ethylmalonyl-CoA was synthesized according to Taoka et al.
(1994).
A typical reaction was performed in reaction buffer (50mMTris-HCl [pH 7.5])
with 80 mM holo-ACP (20 ml of the phosphopantetheinylation reaction, see
above), 3 mM KirCII, 500 mM substrate, and 50 mM MgCl2 in a volume of
25 ml. In negative controls, KirCII was replaced by the same amount of
pET52-proteins. As positive control, direct loading of acyl phosphopante-
theinyl moieties to apo-ACPs by Sfp was used. This resulted in formation of
holo-ACPs and acylated holo-ACPs (malonyl-holo-ACPs, methylmalonyl-
holo-ACPs, and ethylmalonyl-holo-ACPs). The ACP-loading assay samples
were incubated at 37C for 30 min, the reactions were quenched by freezing
at 80C, and samples were stored at 80C until HPLC/ESI-MS analysis.Chemistry & Biology 18,Autoradiography Analysis
The ACP-loading assay was performed with [14C]malonyl-CoA and
[14C]methylmalonyl-CoA. The chemicals, [1,3-14C]malonyl coenzyme A (50–
60 mCi/mmol, 1.85–2.22 GBq/mmol) and [1,3-14C]methylmalonyl coenzyme
A, (50–60 mCi/mmol and 1.85–2.22 GBq/mmol) were purchased from
BIOTREND Chemikalien. To apply various substrate concentrations, the
radiolabeled acyl-CoA derivatives were used directly or diluted with the reac-
tion buffer. In general, the reactions contained 10 mM holo-ACP (2.5 ml of the
phosphopantetheinylation reaction), 50 mM MgCl2, 7–20 mM [
14C]-labeled
substrate, and 0.4–0.7 mM KirCII in 25 ml using 50 mM Tris-HCl (pH 7.5) as
reaction buffer. As positive control reaction direct transfer of the acyl-CoAs
to apo-ACPs by the unspecific phosphopantetheinyl transferase Sfp was
monitored. The negative control was performed with pET52-proteins instead
of KirCII. The reactions were incubated at 37C for 30 min and quenched by
the addition of cold acetone (900 ml). Proteins were precipitated by centrifu-
gation (10 min, 27750 g, Sorvall RC6 PLUS), resolved in 23 sampler buffer,
separated on 12% SDS-PAGE, and blotted onto a nitrocellulose membrane
(BioTrace, pure nitrocellulose, Pall). The membrane was dried on air for 24 hr
and placed into a light tight exposure cassette (Amersham Biosciences) with
a storage phosphor screen (GE Healthcare). After 2 days of incubation time,
the exposed phosphor screen was scanned using Typhoon TRIO+ Variable
Mode Imager, (GE Healthcare) and was analyzed by the software Image-
Quant TL (GE Healthcare).
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